The Clinical and Diagnostic Role of MicroRNAs in Ovarian Carcinoma
Overview
Authors
Affiliations
Objective: MicroRNAs (miRNAs, miRs) are non-coding RNAs which post-transcriptionally regulate mRNA synthesis. Data regarding the expression and clinical relevance of miRNAs and the miRNA-regulating machinery in ovarian carcinoma has been rapidly expanding in recent years. This review presents current knowledge in this area.
Methods: PubMed search was undertaken using the terms 'ovarian' and 'microRNA'.
Results: A total of 492 papers were identified, of which approximately 100 were publications in English focusing exclusively or partly on clinical ovarian carcinoma specimens. These studies have identified multiple miRNAs with a potential role in the diagnosis, biology and progression of ovarian carcinoma, as well as on predicting chemoresponse and determining prognosis.
Conclusions: The presented data support a clinical role for miRNAs in ovarian carcinoma and suggest that miRNA-regulated pathways may be of relevance for novel therapeutics. Novel technologies offer new possibilities for wide-scale miRNA-based classification of OC. Further genomic research focusing on larger series of tumors of similar histological type in combination with experimental approaches is likely to expand our understanding of the role of miRNAs in this cancer.
Ma F, Zhang B, Wang Y, Lou C Molecules. 2024; 29(15).
PMID: 39124865 PMC: 11314102. DOI: 10.3390/molecules29153461.
Minareci Y, Ak N, Sozen H, Tosun O, Kucukgergin C, Aydin F Mol Biol Rep. 2024; 51(1):515.
PMID: 38622482 DOI: 10.1007/s11033-024-09464-y.
Magic and mystery of microRNA-32.
Zeng Z, Zhu Q, Zhao Z, Zu X, Liu J J Cell Mol Med. 2021; 25(18):8588-8601.
PMID: 34405957 PMC: 8435424. DOI: 10.1111/jcmm.16861.
Allegra A, Musolino C, Tonacci A, Pioggia G, Gangemi S Cancers (Basel). 2020; 12(4).
PMID: 32230762 PMC: 7225936. DOI: 10.3390/cancers12040805.
MicroRNA-665 promotes the proliferation of ovarian cancer cells by targeting SRCIN1.
Zhou P, Xiong T, Yao L, Yuan J Exp Ther Med. 2020; 19(2):1112-1120.
PMID: 32010277 PMC: 6966142. DOI: 10.3892/etm.2019.8293.